Last reviewed · How we verify
Aminophylline and Methazolamide — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Aminophylline and Methazolamide (Aminophylline and Methazolamide) — Poudre Valley Health System.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Aminophylline and Methazolamide TARGET | Aminophylline and Methazolamide | Poudre Valley Health System | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Aminophylline and Methazolamide CI watch — RSS
- Aminophylline and Methazolamide CI watch — Atom
- Aminophylline and Methazolamide CI watch — JSON
- Aminophylline and Methazolamide alone — RSS
Cite this brief
Drug Landscape (2026). Aminophylline and Methazolamide — Competitive Intelligence Brief. https://druglandscape.com/ci/aminophylline-and-methazolamide. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab